Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dale L Bailey

Showing results (101-110 of 139) with videos related to

Pageof 14
Sort By:
Asia Oceania Journal of Nuclear Medicine & Biology|February 2, 2026
Confirming the normal range for Mebrofenin liver function indicesKathy P Willowson, Geoff Schembri, Elizabeth A Bailey, et al.
Practical Radiation Oncology|May 7, 2018
Utilizing 18F-fluoroethyltyrosine (FET) positron emission tomography (PET) to define suspected nonenhancing tumor for radiation therapy planning of glioblastomaAimee R Hayes, Dasantha Jayamanne, Edward Hsiao, et al.
Surgical Oncology|April 9, 2026
Biological and comorbidity factors outweigh lymph node metrics in predicting outcomes after small-bowel neuroendocrine tumour resectionKrishna Kotecha, Siddharth Darbhamulla, David L Chan, et al.
Journal of Surgical Oncology|March 30, 2026
Impact of Symptom Phenotype on Surgical Quality and Survival in Small-Bowel Neuroendocrine Tumours: A Quality Metrics AnalysisSiddharth Darbhamulla, Krishna Kotecha, David L Chan, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 13, 2018
Accuracy of Dose Calibrators for <sup>68</sup>Ga PET Imaging: Unexpected Findings in a Multicenter Clinical Pretrial AssessmentDale L Bailey, Michael S Hofman, Nicholas J Forwood, et al.
EJNMMI Physics|September 4, 2018
Comparison of radiobiological parameters for <sup>90</sup>Y radionuclide therapy (RNT) and external beam radiotherapy (EBRT) in vitroYaser H Gholami, Kathy P Willowson, Nicholas J Forwood, et al.
Endocrine Oncology (Bristol, England)|April 8, 2026
Therapy-related myeloid neoplasms following peptide receptor radionuclide therapy for neuroendocrine neoplasms: case series reporting characteristics and outcomes from single-centre experienceWallace Chow, Ivy Wen, Claire Mok, et al.
Physical and Engineering Sciences in Medicine|July 18, 2025
A retrospective comparison of [<sup>18</sup>F]FDG radiation dose following a transition from conventional to long axial field of view PET/CTWei-Ting Jacky Chen, William I D Rae, Peter L Kench, et al.
Asia Oceania Journal of Nuclear Medicine & Biology|June 30, 2025
[<sup>18</sup>F]FMISO PET in metastatic neuroendocrine tumours: a pilot studyDavid L Chan, Alice Conner, Nick Pavlakis, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 13, 2021
Dual PET Imaging in Bronchial Neuroendocrine Neoplasms: The NETPET Score as a Prognostic BiomarkerDavid L Chan, Gary A Ulaner, David Pattison, et al.
Pageof 14

Showing results (101-110 of 139) with videos related to

Sort By:
Pageof 14
Asia Oceania Journal of Nuclear Medicine & Biology|February 2, 2026
Confirming the normal range for Mebrofenin liver function indicesKathy P Willowson, Geoff Schembri, Elizabeth A Bailey, et al.
Practical Radiation Oncology|May 7, 2018
Utilizing 18F-fluoroethyltyrosine (FET) positron emission tomography (PET) to define suspected nonenhancing tumor for radiation therapy planning of glioblastomaAimee R Hayes, Dasantha Jayamanne, Edward Hsiao, et al.
Surgical Oncology|April 9, 2026
Biological and comorbidity factors outweigh lymph node metrics in predicting outcomes after small-bowel neuroendocrine tumour resectionKrishna Kotecha, Siddharth Darbhamulla, David L Chan, et al.
Journal of Surgical Oncology|March 30, 2026
Impact of Symptom Phenotype on Surgical Quality and Survival in Small-Bowel Neuroendocrine Tumours: A Quality Metrics AnalysisSiddharth Darbhamulla, Krishna Kotecha, David L Chan, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 13, 2018
Accuracy of Dose Calibrators for <sup>68</sup>Ga PET Imaging: Unexpected Findings in a Multicenter Clinical Pretrial AssessmentDale L Bailey, Michael S Hofman, Nicholas J Forwood, et al.
EJNMMI Physics|September 4, 2018
Comparison of radiobiological parameters for <sup>90</sup>Y radionuclide therapy (RNT) and external beam radiotherapy (EBRT) in vitroYaser H Gholami, Kathy P Willowson, Nicholas J Forwood, et al.
Endocrine Oncology (Bristol, England)|April 8, 2026
Therapy-related myeloid neoplasms following peptide receptor radionuclide therapy for neuroendocrine neoplasms: case series reporting characteristics and outcomes from single-centre experienceWallace Chow, Ivy Wen, Claire Mok, et al.
Physical and Engineering Sciences in Medicine|July 18, 2025
A retrospective comparison of [<sup>18</sup>F]FDG radiation dose following a transition from conventional to long axial field of view PET/CTWei-Ting Jacky Chen, William I D Rae, Peter L Kench, et al.
Asia Oceania Journal of Nuclear Medicine & Biology|June 30, 2025
[<sup>18</sup>F]FMISO PET in metastatic neuroendocrine tumours: a pilot studyDavid L Chan, Alice Conner, Nick Pavlakis, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 13, 2021
Dual PET Imaging in Bronchial Neuroendocrine Neoplasms: The NETPET Score as a Prognostic BiomarkerDavid L Chan, Gary A Ulaner, David Pattison, et al.
Pageof 14